
zzso zzso cancer is an aggressive disease with at least 50% of patients dying from zzso within 2 years of zzso The zzso survival rate for zzso zzso cancer is zzso Although modern combination chemotherapy regimens have improved median survival from 6 to 14 months compared with best supportive care, there is still a great opportunity for zzso New therapies and strategies for better patient and treatment selection are now being investigated for advanced zzso zzso These include agents that target several pathways involved in the zzso of the zzso as growth factor zzso zzso zzso zzso cell cycle checkpoints and zzso well as novel zzso zzso zzso from recent and ongoing trials suggest that some of these agents could soon emerge as useful players to overcome the limitations of our present zzso 

